MerLion Pharmaceuticals Pte. Ltd. gained two new antibiotics that are about to enter the clinic, plus a platform for identifying novel anti-virulence molecules through its stock-based acquisition of Combinature Biopharm AG and Athelas SA. (BioWorld Today) Read More